Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

LEO Innovation Lab picks next health tech startups to support

Dermatology and mental health firms to receive funds

LEO Pharma

LEO Pharma’s innovation arm has picked five startups to invest in, spreading $5.5m funding between health tech start-ups focusing on dermatology, mental health, skin cancer and brain imaging.

Among those inline for funds are two from San Francisco - Remedly, which is working on streamlining dermatologists’ medical practices and patient care, and mental health tech firm Pacifica, whose consumer-facing mobile and web apps have over 1.25 million registered users.

From Europe LEO is supporting a social network called TalkLife that aims to help young people tackle issues ranging from mental health to bullying by harnessing peer support.

The company is working with Microsoft Research, Massachusetts Institute of Technology and Harvard University to use machine learning and human-in-the-loop computing to better understand and predict self harm.

LEO’s funds will also be shared by SkinVision from the Netherlands, which has developed the first and only CE-certified online risk assessment for skin cancer through its SkinVision app.

Finally, there is investment too for Combinostics from Finland, a firm that’s building data-driven solutions for improved clinical diagnosis and whose first product is a series of artificial intelligence-based  tools for the quantitative assessment of brain images.

Kristian Hart-Hansen, CEO of LEO Innovation Lab, said: "Digital disruption is happening in our market, and we intend to play a pivotal role in setting the agenda for pharma and healthcare innovation by helping startups hatch and commercialise new ideas.

"The companies chosen for seed investment were carefully selected for their ability to digitally disrupt the industry, and to align with our patient-centric vision and values about holistic healthcare."

Set up in 2015, LEO Innovation Lab is an independent operating unit within LEO that focuses on digital innovation but does not develop pharmaceutical products. It has over 70 staff based at five locations - Copenhagen, London, Paris, Toronto and San Francisco – and its profits are reinvested into unit.

29th March 2017

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....